LEVIMUNE Canadian Trademark Information

Pharmaceutical preparations for use in the prevention, diagnosis and treatment of cancers; pharmaceutical preparations for use in the prevention, diagnosis and treatment of neurological disorders, namely, brain diseases, central nervous system movement disorders, multiple sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuropathic pain, neuropathy, amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, traumatic brain injury, nerve damage, demyelination, neuroocular disorders and depression; pharmaceutical preparations for use in the prevention, diagnosis and treatment of cardiovascular disorders; pharmaceutical preparations for use in the prevention, diagnosis and treatment of inflammatory disorders, namely, inflammatory bowel diseases, inflammatory skin diseases, inflammatory joint diseases, and neuroinflammatory diseases; preparations for use in the prevention, diagnosis and treatment of immunoregulatory disorders, namely, autoimmune diseases, psoriasis, rheumatoid arthritis, lupus, systemic lupus erythematosus (SLE), Sjogren's syndrome, transplant rejection (graft-vs-host and host-vs-graft), diabetes and fibrosis; and pharmaceutical prepa...

Perfect for these industries

Pharmaceutical Products

Words that describe this mark

pharmaceutical preparations use prevention diagnosis treatment cancers pharmaceutical preparations use prevention diagnosis treatment neurological disorders brain diseases central nervous movement disorders multiple sclerosis alzheimers disease parkinsons disease huntingtons

Abandonment Notice! On Wednesday, August 6, 2008, status on the LEVIMUNE trademark changed to Interruption of proceeding. Apply Now for this name starting at $449!

CAUTION: Although Canada registration for this particular filing is inactive, the mark may still enjoy common law rights, or may have been applied for again in a separate application. Further research may be warranted to determine where this mark is truly abandoned in commerce.

On Wednesday, January 19, 2005, a canadian trademark registration was filed for LEVIMUNE by BIOGEN IDEC MA INC. a Massachu *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1244719. The current status of this trademark filing is Interruption of proceeding. The LEVIMUNE trademark is filed in the description of Pharmaceutical preparations for use in the prevention, diagnosis and treatment of cancers; pharmaceutical preparations for use in the prevention, diagnosis and treatment of neurological disorders, namely, brain diseases, central nervous system movement disorders, multiple sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuropathic pain, neuropathy, amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, traumatic brain injury, nerve damage, demyelination, neuroocular disorders and depression; pharmaceutical preparations for use in the prevention, diagnosis and treatment of cardiovascular disorders; pharmaceutical preparations for use in the prevention, diagnosis and treatment of inflammatory disorders, namely, inflammatory bowel diseases, inflammatory skin diseases, inflammatory joint diseases, and neuroinflammatory diseases; preparations for use in the prevention, diagnosis and treatment of immunoregulatory disorders, namely, autoimmune diseases, psoriasis, rheumatoid arthritis, lupus, systemic lupus erythematosus (SLE), Sjogren's syndrome, transplant rejection (graft-vs-host and host-vs-graft), diabetes and fibrosis; and pharmaceutical preparations for use in the prevention, diagnosis and treatment of gastrointestinal diseases. , Pharmaceutical preparations for use in the prevention, diagnosis and treatment of cancers; pharmaceutical preparations for use in the prevention, diagnosis and treatment of neurological disorders, namely, brain diseases, central nervous system movement disorders, multiple sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuropathic pain, neuropathy, amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, traumatic brain injury, nerve damage, demyelination, neuroocular disorders and depression; pharmaceutical preparations for use in the prevention, diagnosis and treatment of cardiovascular disorders; pharmaceutical preparations for use in the prevention, diagnosis and treatment of inflammatory disorders, namely, inflammatory bowel diseases, inflammatory skin diseases, inflammatory joint diseases, and neuroinflammatory diseases; preparations for use in the prevention, diagnosis and treatment of immunoregulatory disorders, namely, autoimmune diseases, psoriasis, rheumatoid arthritis, lupus, systemic lupus erythematosus (SLE), Sjogren's syndrome, transplant rejection (graft-vs-host and host-vs-graft), diabetes and fibrosis; and pharmaceutical preparations for use in the prevention, diagnosis and treatment of gastrointestinal diseases. .

Get FREE email alerts

100% Satisfaction Guarantee

protect your valuable brand now.

Classification Information

Class Code:	005 - Pharmaceutical Products
Description:	Pharmaceuticals and herbicides

Matter History Events

Status Date	Record Status Description
2008-08-06	Interruption of proceeding - Abandoned - Subsection 40(3)
2008-01-30	National prosecution history entry - Extension of Time
2007-03-30	National prosecution history entry - Allowed
2007-03-30	National prosecution history entry - Allowance Notice Sent
2007-01-10	Application published - Advertised
2006-12-11	Application accepted - Approved
2006-03-22	National prosecution history entry - Extension of Time
2005-07-27	National prosecution history entry - Extension of Time
2005-05-17	National prosecution history entry - Search Recorded
2005-05-17	National prosecution history entry - Examiner's First Report
2005-01-28	Filing date accorded - Formalized
2005-01-25	National prosecution history entry - Created
2005-01-19	Application filed - Filed

Word Mark:	LEVIMUNE
Current Status:	Interruption of proceeding DEAD Mark! Start a New Filing Request 8/6/2008
Application Number:	1244719
Filing Date:	Wednesday, January 19, 2005
Filing Place:	Canada
Registration Date:	Not Available
Register Type:	Primary
Type Of Mark:	Trademark
Mark Feature:	Word
Use In Commerce:	No
Publication Registration:	Wednesday, January 10, 2007
Opposition:	1/10/2007 - 1/10/2007
Last Applicant/Owner:	BIOGEN IDEC MA INC. A MASSACHU ******* ****** * **
Correspondent:	Not provided

Goods and Services Information
Description:	(1) - Pharmaceutical preparations for use in the prevention, diagnosis and treatment of cancers; pharmaceutical preparations for use in the prevention, diagnosis and treatment of neurological disorders, namely, brain diseases, central nervous system movement disorders, multiple sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuropathic pain, neuropathy, amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, traumatic brain injury, nerve damage, demyelination, neuroocular disorders and depression; pharmaceutical preparations for use in the prevention, diagnosis and treatment of cardiovascular disorders; pharmaceutical preparations for use in the prevention, diagnosis and treatment of inflammatory disorders, namely, inflammatory bowel diseases, inflammatory skin diseases, inflammatory joint diseases, and neuroinflammatory diseases; preparations for use in the prevention, diagnosis and treatment of immunoregulatory disorders, namely, autoimmune diseases, psoriasis, rheumatoid arthritis, lupus, systemic lupus erythematosus (SLE), Sjogren's syndrome, transplant rejection (graft-vs-host and host-vs-graft), diabetes and fibrosis; and pharmaceutical preparations for use in the prevention, diagnosis and treatment of gastrointestinal diseases. (2) - Pharmaceutical preparations for use in the prevention, diagnosis and treatment of cancers; pharmaceutical preparations for use in the prevention, diagnosis and treatment of neurological disorders, namely, brain diseases, central nervous system movement disorders, multiple sclerosis, Alzheimer's disease, Parkinson's disease, Huntington's disease, neuropathic pain, neuropathy, amyotrophic lateral sclerosis (ALS), stroke, spinal cord injury, traumatic brain injury, nerve damage, demyelination, neuroocular disorders and depression; pharmaceutical preparations for use in the prevention, diagnosis and treatment of cardiovascular disorders; pharmaceutical preparations for use in the prevention, diagnosis and treatment of inflammatory disorders, namely, inflammatory bowel diseases, inflammatory skin diseases, inflammatory joint diseases, and neuroinflammatory diseases; preparations for use in the prevention, diagnosis and treatment of immunoregulatory disorders, namely, autoimmune diseases, psoriasis, rheumatoid arthritis, lupus, systemic lupus erythematosus (SLE), Sjogren's syndrome, transplant rejection (graft-vs-host and host-vs-graft), diabetes and fibrosis; and pharmaceutical preparations for use in the prevention, diagnosis and treatment of gastrointestinal diseases.

Perfect for these industries

Words that describe this mark

a canadian trademark registration was filed for by . The Canadian IP office has given the trademark application number of . The current status of this trademark filing is . The correspondent listed for is The trademark is filed in the description of .

Trademarkia is the largest search engine for U.S., China, European Union, Canada, and Australia Trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia network law firms! You can register your trademark in 180+ countries in the world through Trademarkia Network. Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

100% Satisfaction Guarantee

protect your valuable brand now.

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

How it works

1. Trademarkia Network Law firm - #1 Trademark Filing since 2010.

2. Describe how your business or product is being used. Register your mark in 180+ countries.

What you get

1. Top Global Specialist - Credibility and Experience!

2. All processes will be performed in a timely manner. You will be informed periodically about the process.

What our customers say:

I wasn't too sure what to expect when taking up services, but the professionalism from the site to the customer service is the slickest I have ever experienced.

Camryn, Surrey, UK

What You Can Do:

Start Your Business

Get FREE email alerts

Add to Favorites

Start Canada Trademark Filing

Custom Logo Design $99

Search on popular social networks

This mark may be available for re-registration. You can apply for it through Trademarkia at a low cost of $449!

Trademarkia.com will perform a final search in order to verify that this mark is available for Canada Trademark re-registration. All Trademarkia services are backed by a 100% satisfaction guarantee.

Trademarkia lets you see how your personal name, product name, trademark name or username is being used on any of 530+ new and popular social networks. Be the first to reserve your name and get help stopping others from using it - all in one place!

As seen on